PMI U.S. Opens Zyn Manufacturing Campus

Philip Morris International’s U.S. business (PMI U.S.) celebrated the opening of a Colorado manufacturing campus that produces Zyn nicotine pouches on Monday.

The approximately 780,000-square-foot campus is on a 148-acre site and started commercial production this month, according to a news release.

About $1 billion has been invested so far in the Aurora, Colorado, site, but that figure is expected to total $1.2 billion through 2028, according to the release. 

PMI U.S. plans to expand the site and add production capacity and future capabilities to support the growth of Zyn in the United States as well as increasing opportunities in international markets, the release said.

“Aurora represents an important milestone for PMI U.S. and our continued investment in our business here,” said PMI U.S. CEO Stacey Kennedy in the release. “This facility expands our production capacity, strengthens our supply chain, and enhances our ability to serve growing demand in the United States and around the world. It reflects our confidence in American workers, U.S. manufacturing and the long-term growth opportunities ahead for our business.”

Philip Morris International said in an earnings report last week that the business grew its Zyn portfolio in the United States in June with the first shipments of Zyn Ultra 9 mg and 11 mg moist variants with a lower price per pouch. The business also launched additional flavors in the Zyn dry flagship lineup.

The U.S. Food and Drug Administration (FDA) also recently granted modified risk tobacco product authorization on June 30 to the 20 Zyn products it authorized in January 2025.

“To support the newly expanded Zyn portfolio, we intend to accelerate U.S. investments in the second half to maximize the long-term value of the brand and also prepare for the future launch of IQOS ILUMA,” the release said.

PMI launched its IQOS heated tobacco device in 2025.